Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rikke K, Kirk"'
Publikováno v:
Nutrition & Diabetes, Vol 13, Iss 1, Pp 1-5 (2023)
Abstract Aims To investigate the influence of the dose in the FITC-Dextran 4kDa (FD-4) permeability test in an obese mouse model, we tested the bodyweight dose regimen and a lean body mass-based dose regimen in high fat diet (HFD) mice and low fat di
Externí odkaz:
https://doaj.org/article/8c16f181714e492db1c3c4c253eb04ca
Autor:
Laura J. Andreasen, Rikke K. Kirk, Christian Fledelius, Mark A. Yorek, Jens Lykkesfeldt, Thorbjorn Akerstrom
Publikováno v:
Journal of Diabetes Research, Vol 2020 (2020)
Introduction. Current clinical guidelines for management of diabetic peripheral neuropathy (DPN) emphasize good glycemic control. However, this has limited effect on prevention of DPN in type 2 diabetic (T2D) patients. This study investigates the eff
Externí odkaz:
https://doaj.org/article/82193790eb444d748fc4a93e88b90ffb
Autor:
Louise M. Voetmann, Christina R. Underwood, Bidda Rolin, Axel K. Hansen, Rikke K. Kirk, Charles Pyke, Lotte B. Knudsen, Klaus S. Frederiksen
Publikováno v:
Voetmann, L M, Underwood, C R, Rolin, B, Hansen, A K, Kirk, R K, Pyke, C, Knudsen, L B & Frederiksen, K S 2022, ' In vitro cell cultures of Brunner's glands from male mouse to study GLP-1 receptor function ', American journal of physiology. Cell physiology, vol. 322, no. 6, pp. C1260-C1269 . https://doi.org/10.1152/ajpcell.00345.2021
Exocrine glands in the submucosa of the proximal duodenum secrete alkaline fluid containing mucus to protect the intestinal mucosa from acidic stomach contents. These glands, known as Brunner’s glands, express high glucagon-like peptide 1 receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d56cc99bef32b6101469030ddfc5a830
https://doi.org/10.1152/ajpcell.00345.2021
https://doi.org/10.1152/ajpcell.00345.2021
Autor:
Vivi F. H. Jensen, Line H. Schefe, Helene Jacobsen, Anne-Marie Mølck, Kasper Almholt, Ingrid Sjögren, Charlotte M. Dalsgaard, Rikke K Kirk, Andrew J. Benie, Bent O. Petersen, Mette S. Kyhn, Anne J. Overgaard, Inga Bjørnsdottir, Diane R. Stannard, Hanne K. Offenberg, Emil Egecioglu
Publikováno v:
International journal of toxicology. 41(6)
N9-GP/Rebinyn®/Refixia® is an approved PEGylated (polyethylene glycol-conjugated) recombinant human factor IX intended for prophylactic and/or on-demand treatment in adults and children with haemophilia B. A juvenile neurotoxicity study was conduct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::096486a188ecd8cd186b879e03896bbe
https://pubmed.ncbi.nlm.nih.gov/36036386
https://pubmed.ncbi.nlm.nih.gov/36036386
Publikováno v:
Nutritiondiabetes. 13(1)
To investigate the influence of the dose in the FITC-Dextran 4kDa (FD-4) permeability test in an obese mouse model, we tested the bodyweight dose regimen and a lean body mass-based dose regimen in high fat diet (HFD) mice and low fat diet (LFD) mice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::56d3cde539725144f20fc6715e0f3ba5
https://pubmed.ncbi.nlm.nih.gov/36604407
https://pubmed.ncbi.nlm.nih.gov/36604407
Autor:
Bidda Rolin, Rikke K Kirk, Carsten Gotfredsen, Barbara H Bjerring, Thomas Klitgaard, Janos T Kodra, Malene Mohr, Salka E Rasmussen
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 32
Objective: The apoA-I mimetic peptide L-4F has previously been shown to have antidiabetic efficacy in ob/ob mice. In this study we tested the antidiabetic potential of the D-4F peptide. Methods: We dosed 6 weeks old male db/db mice once daily with 4.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::918b7bd2cd27715ad3b6ad22dee11e65
https://doi.org/10.1161/atvb.32.suppl_1.a467
https://doi.org/10.1161/atvb.32.suppl_1.a467